Skip to main content
Surya Bhatt, MD, Pulmonology, Birmingham, AL

Surya Prakash Bhatt MD MSPH

Asthma & COPD, Pulmonary Rehabilitation


Professor of Medicine, University of Alabama at Birmingham

Join to View Full Profile
  • 2000 6th Avenue SouthBirmingham, AL 35233

  • Phone+1 205-934-5555

Dr. Bhatt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Medical Director, Pulmonary Function and Exercise Physiology Lab
    Medical Director, Pulmonary Rehabilitation/Telehealth Pulmonary Rehabilitation
    Director, UAB Lung Imaging Lab

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
  • St Luke's University Hospital
    St Luke's University HospitalResidency, Internal Medicine, 2006 - 2009
  • Mysore Medical College
    Mysore Medical CollegeClass of 2001

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2012 - 2025
  • SC State Medical License
    SC State Medical License 2017 - 2021
  • NC State Medical License
    NC State Medical License 2017 - 2020
  • IA State Medical License
    IA State Medical License 2008 - 2013
  • PA State Medical License
    PA State Medical License 2006 - 2009
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Dupilumab Improves Quality of Life for COPD Patients
    Dupilumab Improves Quality of Life for COPD PatientsOctober 10th, 2024
  • Dupixent® (Dupilumab) Late-Breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of Medicine
    Dupixent® (Dupilumab) Late-Breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of MedicineMay 21st, 2023
  • Dupixent® (Dupilumab) Late-Breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of Medicine
    Dupixent® (Dupilumab) Late-Breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of MedicineMay 21st, 2023
  • Join now to see all

Grant Support

  • 1/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD)UNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2027
  • 1/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD)UNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2027
  • Structural Determinants of Disease Progression in COPDUNIVERSITY OF ALABAMA AT BIRMINGHAM2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: